Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schnell

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|April 29, 1998
[Indications and limits of nerve block techniques]B Donner, P Schnell, M Zenz
International Journal of Molecular Sciences|June 2, 2021
Latency Reversing Agents: Kick and Kill of HTLV-1?Annika P Schnell, Stephan Kohrt, Andrea K Thoma-Kress
La Nouvelle Presse Medicale|October 14, 1978
[The "e" antigen system in HBs antigen carriers (author's transl)]P Schnell, A M Courouce, P Opolon, et al.
Radiation Research|June 22, 2001
Thyroid cancer after diagnostic administration of iodine-131 in childhoodK Hahn, P Schnell-Inderst, B Grosche, et al.
Nuklearmedizin. Nuclear Medicine|February 24, 2006
Diagnostic nuclear medicine procedures in Germany between 1996 and 2002: application frequencies and collective effective dosesA Stamm-Meyer, D Nosske, P Schnell-Inderst, et al.
Applied Optics|August 10, 1997
Demonstration of optically controlled data routing with the use of multiple-quantum-well bistable and electro-optical devicesP Koppa, P Chavel, J L Oudar, et al.
Nuklearmedizin. Nuclear Medicine|March 19, 2004
[Acquisition of age- and sex-dependent patient data for the calculation of annual radiation exposure in nuclear medicine: a German pilot study]P Schnell-Inderst, M Hacker, D Nosske, et al.
Nuklearmedizin. Nuclear Medicine|September 16, 2005
[Radiation exposure of patients undergoing nuclear medicine procedures in Germany between 1996 and 2000. Multicenter evaluation of age and gender-specific patient data]M Hacker, P Schnell-Inderst, D Nosske, et al.
Frontiers in Immunology|September 2, 2022
HDAC inhibitors Panobinostat and Romidepsin enhance <i>tax</i> transcription in HTLV-1-infected cell lines and freshly isolated patients' T-cellsAnnika P Schnell, Stephan Kohrt, Aris Aristodemou, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2011
Cost-effectiveness of primary HPV screening for cervical cancer in Germany--a decision analysisG Sroczynski, P Schnell-Inderst, N Mühlberger, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|April 29, 1998
[Indications and limits of nerve block techniques]B Donner, P Schnell, M Zenz
International Journal of Molecular Sciences|June 2, 2021
Latency Reversing Agents: Kick and Kill of HTLV-1?Annika P Schnell, Stephan Kohrt, Andrea K Thoma-Kress
La Nouvelle Presse Medicale|October 14, 1978
[The "e" antigen system in HBs antigen carriers (author's transl)]P Schnell, A M Courouce, P Opolon, et al.
Radiation Research|June 22, 2001
Thyroid cancer after diagnostic administration of iodine-131 in childhoodK Hahn, P Schnell-Inderst, B Grosche, et al.
Nuklearmedizin. Nuclear Medicine|February 24, 2006
Diagnostic nuclear medicine procedures in Germany between 1996 and 2002: application frequencies and collective effective dosesA Stamm-Meyer, D Nosske, P Schnell-Inderst, et al.
Applied Optics|August 10, 1997
Demonstration of optically controlled data routing with the use of multiple-quantum-well bistable and electro-optical devicesP Koppa, P Chavel, J L Oudar, et al.
Nuklearmedizin. Nuclear Medicine|March 19, 2004
[Acquisition of age- and sex-dependent patient data for the calculation of annual radiation exposure in nuclear medicine: a German pilot study]P Schnell-Inderst, M Hacker, D Nosske, et al.
Nuklearmedizin. Nuclear Medicine|September 16, 2005
[Radiation exposure of patients undergoing nuclear medicine procedures in Germany between 1996 and 2000. Multicenter evaluation of age and gender-specific patient data]M Hacker, P Schnell-Inderst, D Nosske, et al.
Frontiers in Immunology|September 2, 2022
HDAC inhibitors Panobinostat and Romidepsin enhance <i>tax</i> transcription in HTLV-1-infected cell lines and freshly isolated patients' T-cellsAnnika P Schnell, Stephan Kohrt, Aris Aristodemou, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2011
Cost-effectiveness of primary HPV screening for cervical cancer in Germany--a decision analysisG Sroczynski, P Schnell-Inderst, N Mühlberger, et al.
Pageof 1